Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.60 EUR | -0.18% | -2.79% | +17.35% |
09-09 | German Shares Cheer Likelihood of September ECB Rate Cut | MT |
09-03 | Merck Gets EU Approval for Keytruda Cancer Therapy | DJ |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Merck KGaA Reports Decline in H1 Attributable Profit, Net Sales